Mangalam Drugs & Organics Limited Share Price NSE India S.E.
Stocks
MANGALAM
INE584F01014
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.11 INR | +0.15% |
|
-0.40% | -1.45% |
| Market Cap | 439M 4.6M 4M 3.72M 3.42M 6.45M 6.55M 43.87M 17.22M 219M 17.27M 16.89M 733M | P/E 2024 |
-16.2x | P/E 2025 | 17.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.38B 14.41M 12.53M 11.66M 10.7M 20.21M 20.53M 137M 53.94M 685M 54.11M 52.93M 2.3B | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.66x |
| Free-Float |
62.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 04/02/22 | Mangalam Drugs & Organics : Resignation | PU |
| 1 day | +0.15% | ||
| 1 week | -0.40% | ||
| 1 month | -3.66% | ||
| 3 months | -8.04% | ||
| 6 months | -25.11% | ||
| Current year | -1.45% |
| 1 week | 26.33 |  | 27.8 |
| 1 month | 26.33 | | 29.3 |
| Current year | 26.33 | | 54.4 |
| 1 year | 22.8 | | 90.85 |
| 3 years | 22.8 | | 144.99 |
| 5 years | 22.8 | | 194.15 |
| 10 years | 20.65 | | 225.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 72 | 29/09/2011 | |
| Director of Finance/CFO | - | 05/02/2026 | |
Shweta Patel
CMP | Compliance Officer | 27 | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 01/02/2010 | |
| Director/Board Member | 75 | 04/02/2015 | |
Nidhi S. Mundada
BRD | Director/Board Member | 37 | 27/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | -0.40% | - | - | 4.56M | |
| -0.53% | +2.54% | +16.63% | +74.09% | 50.03B | |
| -1.81% | -0.49% | +51.99% | +112.44% | 36.6B | |
| +0.46% | +4.44% | -5.24% | +25.38% | 12.47B | |
| +1.05% | +1.63% | +16.19% | +78.22% | 11.77B | |
| -1.33% | -0.76% | +30.08% | +131.70% | 9.04B | |
| -2.99% | -2.09% | +41.02% | -8.36% | 7.03B | |
| +0.51% | +1.46% | +12.17% | +32.88% | 6.79B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +1.99% | +1.91% | +4.68% | +183.54% | 6.6B | |
| Average | -0.25% | +1.00% | +20.94% | +78.74% | 16.35B | |
| Weighted average by Cap. | -0.62% | +1.27% | +25.18% | +82.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.67B 38.48M 33.45M 31.14M 28.59M 53.99M 54.82M 367M 144M 1.83B 145M 141M 6.13B | 3.18B 33.27M 28.92M 26.92M 24.71M 46.67M 47.39M 317M 125M 1.58B 125M 122M 5.3B |
| Net income | -90.72M -950K -826K -769K -706K -1.33M -1.35M -9.06M -3.56M -45.16M -3.57M -3.49M -151M | 67.21M 704K 612K 570K 523K 988K 1M 6.71M 2.64M 33.46M 2.64M 2.59M 112M |
| Net Debt | 1.06B 11.08M 9.63M 8.97M 8.23M 15.55M 15.79M 106M 41.49M 527M 41.63M 40.71M 1.77B | 936M 9.81M 8.53M 7.94M 7.29M 13.76M 13.97M 93.56M 36.72M 466M 36.84M 36.03M 1.56B |
Employees
480
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹27.11 | +0.15% | 8,754 |
| 30/07/26 | ₹27.07 | -0.26% | 24,198 |
| 29/07/26 | ₹27.14 | -1.17% | 25,640 |
| 28/07/26 | ₹27.46 | +0.15% | 18,804 |
| 27/07/26 | ₹27.42 | +0.73% | 8,630 |
- Stock Market
- Stocks
- MANGALAM Stock
- MANGALAM Stock
Select your edition
All financial news and data tailored to specific country editions
